ABCs Report: Streptococcus pneumoniae, 2002
February 2, 2010: Content on this page kept for historical reasons.
Active Bacterial Core Surveillance (ABCs): Emerging Infections Program Network
California (San Francisco County and children <5 years in Alameda and Contra Costa counties); Colorado (5 county Denver area); Connecticut; Georgia (20 county Atlanta area); Maryland (6 county Baltimore area); Minnesota; New York (7 county Rochester area and 8 county Albany area); Oregon (3 county Portland area); Tennessee (11 urban counties)
The surveillance areas represent 25,051,246 persons. Source: National Center for Health Statistics bridged-race vintage 2002 postcensal file
ABCs Case Definition
Invasive pneumococcal disease: isolation of Streptococcus pneumoniae from normally sterile site in resident of a surveillance area in 2002.
Project personnel communicated at least monthly with contacts in all microbiology laboratories serving acute care hospitals in their area to identify cases. A standardized case report form included information on demographic characteristics, clinical syndrome, and illness outcome and was completed for each case. Pneumococcal isolates were collected, tested for susceptibility at reference laboratories using NCCLS methods, and serotyped at CDC. Regular laboratory audits assessed completeness of active surveillance and detected additional cases.
Rates of invasive pneumococcal disease were calculated using population estimates for 2002. For national projections, race- and age-specific rates of disease were applied from the aggregate surveillance area to the age and racial distribution of the 2002 U. S. population. Cases with unknown race were distributed by area based on reported race distribution for known cases within the eight age categories.
Reported ABCs Profiles
Unknown race (n=493) distributed among knowns.
* Cases per 100,000 population for ABCs areas
Centers for Disease Control and Prevention. 2003. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Streptococcus pneumoniae, 2002.
|<1||148 (38.5)||3 (0.8)|
|1||121 (31.5)||0 (0.0)|
|2-4||172 (15.8)||3 (0.3)|
|5-17||145 (3.2)||8 (0.2)|
|18-34||243 (4.1)||13 (0.2)|
|35-49||801 (13.3)||97 (1.6)|
|50-64||733 (18.7)||109 (2.8)|
|≥ 65||1,199 (43.3)||247 (8.9)|
|Total||3,562 (14.2)||480 (1.9)|
*Cases or deaths per 100,000 population for ABCs areas
|Bacteremia without focus||751||(21.1)|
|Pneumonia with bacteremia||2,454||(68.9)|
*Percent of cases
Based on reference lab testing of 3,120 isolates.
* Susceptible; † Intermediate; ‡ Resistant based on year 2002 NCCLS definitions except for cefotaxime (2001 and 2002) (2001 NCCLS definition)
National Projections of Invasive Disease
Cases: 40,900 (14.2/100,000)
Deaths: 5,700 (2.0/100,000)
Healthy People 2010 Update
Objective: Decrease the incidence of invasive pneumococcal infections to 46 per 100,000 persons less than 5 years of age and to 42 per 100,000 persons aged 65 and older.
|Age (year)||2010 Objective||2002 Rate*|
*Cases per 100,000 U.S. population < 5 years or ≥ 65 years